M Zankel

Treatment of Acute Hepatitis C with Interferon Alfa-2b

Elmar Jaeckel, Markus Cornberg, Heiner Wedemeyer et al. · New England Journal of Medicine · 2001 · 802 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B

Karsten Wursthorn, Marc Lütgehetmann, Maura Dandri et al. · Hepatology · 2006 · 439 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Sequential Combination Therapy Leads to Biochemical and Histological Improvement Despite Low Ongoing Intrahepatic Hepatitis B virus Replication

Marc Lütgehetmann, Tassilo Volz, Alexander Quaas et al. · Antiviral Therapy · 2008 · 70 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1–infected patients†‡

Thomas Berg, V Weich, G Teuber et al. · Hepatology · 2009 · 55 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Randomized, controlled trial with IFN-α combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis C

G Teuber, M. Pascu, Thomas Berg et al. · Journal of Hepatology · 2003 · 40 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13